MGN 1280x720 60923P00 LEWJL

Sen. Klobuchar is calling on top health officials to address the drug shortage

In a letter to top health officials, Senator Amy Klobuchar, and three of her fellow senators, urged that the amoxicillin shortage be addressed.

“We are writing to express our strong concern about the shortage of amoxicillin,” the letter begins.

The four senators called on the US Department of Health and Human Services (HHS), the US Food and Drug Administration (FDA) to “convene the Drug Shortage Task Force and work with stakeholders, including providers, to identify factors and identify possible solutions to reduce the amoxicillin shortage.”

The urgency is shared as much of the country — including Minnesota — deals with sharp increases in respiratory illnesses.

Data from the Minnesota Department of Health (MDH) shows as of November 19, there have been an additional 240 school outbreaks. There have been 564 school outbreaks nationwide since the first week of October.

RELATED: School flu outbreaks continue to grow across Minnesota

“We are considering amoxicillin [a] first-line therapy, because it treats bacterial infection well,” said Dr. Gigi Chawla, vice president and chief of general pediatrics at Children’s Minnesota, said.

Chawla said Children’s Minnesota is feeling the impact.

“It [challenges] our clinicians to come up with alternative choices,” Dr. Chawla said about the limited access to amoxicillin. “Sometimes the unexpected consequences are shortages of those second-line therapies.”

She was encouraged by Sen. Klobuchar’s push to address the deficit.

“I think the attention is definitely worth it, and hopefully [it] may drive some impact, or at least make it top of mind, for some of these drug companies,” Dr. Chawla said.

To learn more about how Children’s Minnesota can help, click here.

Related Posts